Asgct's mission is to advance knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease.
In care of DR George Stamatoyannopoulos PRES
Donations are tax-deductible
Category
Other
Employees
48
Volunteers
19
Financial Snapshot
FY ending 2024-12-31
Revenue
$16.9M
Expenses
$14.6M
Assets
$27.0M
Liabilities
$6.7M
Financial history
$16.9M$8.5M$0
161718192021222324
RevenueExpenses
Latest FY2024: $16.9M · Avg: $7.8M
Foreign activity (Schedule F)
Total spent abroad$49K
Foreign employees0
Foreign offices0
Foreign partnership interestNo
Foreign trust interestNo
Region
Activity
Spent
EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA,
—
—
NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES
—
—
MIDDLE EAST AND NORTH AFRICA - ALGERIA, BAHRAIN, DJIBOUTI, EGYPT,
—
—
EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM